Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -57.74% is 41% below its 5-year average of -40.90%, around the middle of its 5-year range (-88.03%–8.51%).
As of the fiscal period ended Tuesday, June 30, 2026. 11.16% below its 12-month average of -51.94%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -57.74%.
RETURN ON INVESTED CAPITAL (ROIC)
-57.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-51.94%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-48.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-40.90%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-52.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-11.16%
CURRENT VS 3Y AVG
-19.00%
CURRENT VS 5Y AVG
-41.16%
CURRENT VS 10Y AVG
-10.25%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.98%
median of 702 covered companies
CURRENT VS SECTOR MEDIAN
-69.90%
vs the sector median at left
Lipocine Inc.
Market Cap
$17.19M
Return on Invested Capital (ROIC)
-57.74%
TTM Avg
-51.94%
3Y Avg
-48.52%
5Y Avg
-40.90%
Market Cap
$17.13M
Return on Invested Capital (ROIC)
-88.07%
TTM Avg
-68.32%
3Y Avg
-78.67%
5Y Avg
-76.64%
Market Cap
$17.27M
Return on Invested Capital (ROIC)
-73.92%
TTM Avg
-122.57%
3Y Avg
-184.65%
5Y Avg
-161.38%
Market Cap
$17.59M
Return on Invested Capital (ROIC)
-46.69%
TTM Avg
-40.71%
3Y Avg
-34.73%
5Y Avg
-24.39%
Market Cap
$16.73M
Return on Invested Capital (ROIC)
-125.44%
TTM Avg
-125.44%
3Y Avg
-1118.57%
5Y Avg
-719.84%
Market Cap
$16.70M
Return on Invested Capital (ROIC)
-85.72%
TTM Avg
-120.02%
3Y Avg
-101.35%
5Y Avg
-83.66%
Market Cap
$16.49M
Return on Invested Capital (ROIC)
-279.48%
TTM Avg
-96.52%
3Y Avg
-105.30%
5Y Avg
-89.17%
Market Cap
$16.00M
Return on Invested Capital (ROIC)
-273.70%
TTM Avg
-707.06%
3Y Avg
-535.27%
5Y Avg
-358.40%
Market Cap
$18.40M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-171.06%
3Y Avg
-106.73%
5Y Avg
-106.73%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lipocine Inc. (LPCN) | $17.19M | -57.74% | -51.94% | -48.52% | -40.90% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.13M | -88.07% | -68.32% | -78.67% | -76.64% |
| PAVmed Inc. (PAVM)vs › | $17.27M | -73.92% | -122.57% | -184.65% | -161.38% |
| Cosmos Health Inc. (COSM)vs › | $17.59M | -46.69% | -40.71% | -34.73% | -24.39% |
| Palatin Technologies, Inc. (PTN)vs › | $16.73M | -125.44% | -125.44% | -1118.57% | -719.84% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.70M | -85.72% | -120.02% | -101.35% | -83.66% |
| Dyadic International, Inc. (DYAI)vs › | $16.49M | -279.48% | -96.52% | -105.30% | -89.17% |
| BioCardia, Inc. (BCDA)vs › | $16.00M | -273.70% | -707.06% | -535.27% | -358.40% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.40M | N/A | -171.06% | -106.73% | -106.73% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.54M | -49.83% | -1.54% | -82.67% | -67.29% |
ROIC
-57.7%
ROE
-54.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -57.74% |
| 2026-03-31 | -53.13% |
| 2025-12-31 | -71.64% |
| 2025-09-30 | -44.62% |
| 2025-06-30 | -32.57% |
| 2025-03-31 | -33.69% |
| 2024-12-31 | -5.09% |
| 2024-09-30 | -27.69% |
| 2024-06-30 | -45.77% |
| 2024-03-31 | -43.29% |
| 2023-12-31 | -88.03% |
| 2023-09-30 | -79.51% |
| 2023-06-30 | -48.00% |
| 2023-03-31 | -41.53% |
| 2022-12-31 | -33.79% |
| 2022-09-30 | 8.51% |
| 2022-06-30 | 6.40% |
| 2022-03-31 | 6.87% |
| 2021-12-31 | 6.40% |
| 2021-09-30 | -38.93% |
| 2021-06-30 | -36.10% |
| 2021-03-31 | -34.04% |
| 2020-12-31 | -81.42% |
| 2020-09-30 | -75.07% |
| 2020-06-30 | -70.62% |
| 2020-03-31 | -77.27% |
| 2019-12-31 | -71.56% |
| 2019-09-30 | -81.76% |
| 2019-06-30 | -64.63% |
| 2019-03-31 | -53.59% |
| 2018-12-31 | -57.51% |
| 2018-09-30 | -61.74% |
| 2018-06-30 | -66.52% |
| 2018-03-31 | -70.86% |
| 2017-12-31 | -111.79% |
| 2017-09-30 | -77.77% |
| 2017-06-30 | -66.10% |
| 2017-03-31 | -65.51% |
| 2016-12-31 | -70.95% |
| 2016-09-30 | -64.98% |
| 2016-06-30 | -70.59% |
| 2016-03-31 | -56.40% |
| 2015-12-31 | -38.30% |
| 2015-09-30 | -38.37% |
| 2015-06-30 | -29.60% |
| 2015-03-31 | -76.57% |
| 2014-12-31 | -77.70% |
| 2014-09-30 | -66.49% |
| 2014-06-30 | -54.86% |
| 2014-03-31 | -31.28% |
| 2013-12-31 | -19.54% |
| 2013-09-30 | -17.27% |
